BioSpace News Archive

QIAGEN N.V. Hereditary And Rare Disease Solution Chosen By Genomics England

January 31, 2017
·
5 min read
Drug Development

Angion Biomedica Corp.'s Phase 2 “GUARD” Clinical Trial Of BB3 In Acute Kidney Injury (AKI) Underway; Complements Ongoing Phase 3 Study In Renal Transplant Recipients With Delayed Graft Function (DGF)

January 31, 2017
·
2 min read
BioMidwest

HematoGenix Announces The Recognition By Merck & Co. As One Of The National Reference Laboratories Offering PD-L1 Testing For KEYTRUDA

January 31, 2017
·
2 min read
Policy

OptiNose AS Announces FDA Acceptance For Filing Of The New Drug Application For OPN-375

January 31, 2017
·
3 min read
Business

Zimmer Biomet Reports Fourth Quarter And Full-Year 2016 Financial Results

January 31, 2017
·
2 min read
Drug Development

Tenax Therapeutics’s Phase 3 LEVO-CTS Trial in Cardiac Surgery Did Not Achieve Dual Endpoint

January 31, 2017
·
4 min read
Business

Owens & Minor Plans To Release 4th Quarter & Full Year 2016 Financial Results On Tuesday, February 14, 2017

January 31, 2017
·
1 min read
Intralink Spine’s Réjuve Treatment Nears Completion Of Safety Study And Begins Multi-Site Pivotal Study

January 31, 2017
·
2 min read
Dimerix Key Patent Allowed In Japan For Use Of Lead Drug Candidate In The Treatment Of Kidney Disease

January 31, 2017
·
1 min read
Genetown

Cambridge Isotope Laboratories, Inc. Is Pleased To Offer Mouse Express NeuCode Mouse Feed

January 31, 2017
·
1 min read